Merck KGaA (OTCMKTS:MKKGY) Reaches New 1-Year Low – Time to Sell?

Merck KGaA (OTCMKTS:MKKGYGet Free Report) reached a new 52-week low during trading on Thursday . The company traded as low as $28.96 and last traded at $29.08, with a volume of 139382 shares changing hands. The stock had previously closed at $29.31.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group assumed coverage on shares of Merck KGaA in a research report on Thursday, September 19th. They issued a “buy” rating on the stock.

Get Our Latest Report on Merck KGaA

Merck KGaA Trading Down 0.8 %

The company has a 50-day moving average of $33.95 and a 200 day moving average of $35.05. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The company has a market cap of $18.79 billion, a PE ratio of 18.09, a price-to-earnings-growth ratio of 2.30 and a beta of 0.96.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Read More

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.